MedPath

Description and Modeling of Swallowing Disorders After a Stroke

Conditions
Stroke
Swallowing Disorders
Registration Number
NCT02974530
Lead Sponsor
University Hospital, Grenoble
Brief Summary

The oropharyngeal junction participates in 3 interpenetrating functions: Swallowing, Breathing and Speech. In the context of ischemic or hemorrhagic stroke, these are altered, isolated or associated manner, causing major disorders and representing a source of handicap for patients.

Understanding the swallowing mechanisms is therefore a major challenge to guide the rehabilitation and improve the initial and long-term prognosis of patients with stroke.

The main objective of this study is to describe and modeling, thanks to a clinical, physiological and radiological knowledge base, swallowing, speech and breathing, in patients with stroke and in healthy subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • First stroke confirmed by MRI < 15 days
  • No severe leukoaraiosis
  • Swallowing disorders identified (GUSS scale < 20)
  • Neurological deficit identified (NIHSS scale <15)
  • Patient able to cooperate for investigations
  • Informed consent signed
Exclusion Criteria
  • Cerebral hemorrhage
  • History of neurological disease that can lead to swallowing disorders
  • History of laryngological disease such as previous surgery or radiation neck
  • Tracheotomy
  • Vigilance disorders
  • Pregnant, parturient or nursing woman
  • Protected adult
  • Simultaneous participation in another study
  • Non registered to the French social security system

For healthy subjects

Inclusion Criteria :

  • Age between 18 and 40 years old
  • French native speaker
  • Normal hearing with or without corrective
  • No oral or written language disorders
  • No neurological or psychiatric disorders
  • Informed consent signed

Exclusion Criteria

  • MRI contraindication
  • Pregnant, parturient or nursing woman
  • Simultaneous participation in another study
  • Non registered to the French social security system

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of Clinical severity scoreAt inclusion and 6 months after diagnosis

NIHSS scale

Change of swallowing disorderWithin 15 days after diagnosis and 6 months after diagnosis

Test : GUgging Swallowing Screen

Secondary Outcome Measures
NameTimeMethod
Change of aphasia disorderWithin 15 days after diagnosis and 6 months after diagnosis

Questionnaire : Aphasia rapid test

Change of behavioural attentionWithin 15 days after diagnosis and 6 months after diagnosis

Questionnaire : Catherine Bergego scale

Change of state of depression and anxietyWithin 15 days after diagnosis and 6 months after diagnosis

Questionnaire : anxiety and depression scale

Trial Locations

Locations (2)

Hospital

🇫🇷

Aix en Provence, France

University hospital

🇫🇷

Montpellier, France

Hospital
🇫🇷Aix en Provence, France
Dominique Gayraud, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.